APO Research
Talk to an analyst

APO RESEARCH · REPORT

Porcine Medicine and Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Porcine Medicine and Vaccines Market Outlook and Growth Opportunities 2026

2 January 2026206 pages

Choose your research edition.

Industry ResearchPorcine Medicine and Vaccines Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Porcine Medicine and Vaccines Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Porcine Medicine and Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Porcine Medicine and Vaccines Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Porcine Medicine and Vaccines Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

The global Porcine Medicine and Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Porcine Medicine and Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Porcine Medicine and Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Porcine Medicine and Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Porcine Medicine and Vaccines market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Porcine Medicine and Vaccines market include Merck, Jinyu Bio-Technology, ChengDu Tecbond, Zoetis, WINSUN, Virbac, Tecon, Ringpu Biology and HVRI, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Porcine Medicine and Vaccines market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Porcine Medicine and Vaccines and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Porcine Medicine and Vaccines revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Porcine Medicine and Vaccines market.

Porcine Medicine and Vaccines Segment by Company

Merck

Jinyu Bio-Technology

ChengDu Tecbond

Zoetis

WINSUN

Virbac

Tecon

Ringpu Biology

HVRI

Hipra

Hile Bio

DHN

Chopper Biology

Ceva

CAVAC

CAHIC

Boehringer Ingelheim

Bioveta

Porcine Medicine and Vaccines Segment by Type

Medicine

Vaccines

Porcine Medicine and Vaccines Segment by Application

Government Tender

Market Sales

Porcine Medicine and Vaccines Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Porcine Medicine and Vaccines status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Porcine Medicine and Vaccines key companies, revenue, market share, and recent developments.

3. To split the Porcine Medicine and Vaccines breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Porcine Medicine and Vaccines market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Porcine Medicine and Vaccines significant trends, drivers, influence factors in global and regions.

6. To analyze Porcine Medicine and Vaccines competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Porcine Medicine and Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Porcine Medicine and Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Porcine Medicine and Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Porcine Medicine and Vaccines industry.

Chapter 3: Detailed analysis of Porcine Medicine and Vaccines company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Porcine Medicine and Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Porcine Medicine and Vaccines in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Porcine Medicine and Vaccines Industry Trends Table 2. Porcine Medicine and Vaccines Industry Drivers Table 3. Porcine Medicine and Vaccines Industry Opportunities and Challenges Table 4. Porcine Medicine and Vaccines Industry Restraints Table 5. Global Porcine Medicine and Vaccines Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Porcine Medicine and Vaccines Revenue Share by Company (2021-2026) Table 7. Global Porcine Medicine and Vaccines Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Porcine Medicine and Vaccines Key Company Manufacturing Base & Headquarters Table 9. Global Porcine Medicine and Vaccines Company, Product Type & Application Table 10. Global Porcine Medicine and Vaccines Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Porcine Medicine and Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Medicine Table 15. Significant Companies of Vaccines Table 16. Global Porcine Medicine and Vaccines Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Porcine Medicine and Vaccines Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Porcine Medicine and Vaccines Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Porcine Medicine and Vaccines Sales Value Share by Type (2021-2026) Table 20. Global Porcine Medicine and Vaccines Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Government Tender Table 22. Significant Companies of Market Sales Table 23. Global Porcine Medicine and Vaccines Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global Porcine Medicine and Vaccines Sales Value by Application (2021-2026) & (US$ Million) Table 25. Global Porcine Medicine and Vaccines Sales Value by Application (2027-2032) & (US$ Million) Table 26. Global Porcine Medicine and Vaccines Sales Value Share by Application (2021-2026) Table 27. Global Porcine Medicine and Vaccines Sales Value Share by Application (2027-2032) Table 28. Global Porcine Medicine and Vaccines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Porcine Medicine and Vaccines Sales Value by Region (2021-2026) & (US$ Million) Table 30. Global Porcine Medicine and Vaccines Sales Value Share by Region (2021-2026) Table 31. Global Porcine Medicine and Vaccines Sales Value by Region (2027-2032) & (US$ Million) Table 32. Global Porcine Medicine and Vaccines Sales Value Share by Region (2027-2032) Table 33. Global Porcine Medicine and Vaccines Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Porcine Medicine and Vaccines Sales Value by Country (2021-2026) & (US$ Million) Table 35. Global Porcine Medicine and Vaccines Sales Value Market Share by Country (2021-2026) Table 36. Global Porcine Medicine and Vaccines Sales Value by Country (2027-2032) & (US$ Million) Table 37. Global Porcine Medicine and Vaccines Sales Value Market Share by Country (2027-2032) Table 38. Merck Company Information Table 39. Merck Business Overview Table 40. Merck Porcine Medicine and Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 41. Merck Porcine Medicine and Vaccines Product Portfolio Table 42. Merck Recent Development Table 43. Jinyu Bio-Technology Company Information Table 44. Jinyu Bio-Technology Business Overview Table 45. Jinyu Bio-Technology Porcine Medicine and Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Jinyu Bio-Technology Porcine Medicine and Vaccines Product Portfolio Table 47. Jinyu Bio-Technology Recent Development Table 48. ChengDu Tecbond Company Information Table 49. ChengDu Tecbond Business Overview Table 50. ChengDu Tecbond Porcine Medicine and Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. ChengDu Tecbond Porcine Medicine and Vaccines Product Portfolio Table 52. ChengDu Tecbond Recent Development Table 53. Zoetis Company Information Table 54. Zoetis Business Overview Table 55. Zoetis Porcine Medicine and Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Zoetis Porcine Medicine and Vaccines Product Portfolio Table 57. Zoetis Recent Development Table 58. WINSUN Company Information Table 59. WINSUN Business Overview Table 60. WINSUN Porcine Medicine and Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. WINSUN Porcine Medicine and Vaccines Product Portfolio Table 62. WINSUN Recent Development Table 63. Virbac Company Information Table 64. Virbac Business Overview Table 65. Virbac Porcine Medicine and Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Virbac Porcine Medicine and Vaccines Product Portfolio Table 67. Virbac Recent Development Table 68. Tecon Company Information Table 69. Tecon Business Overview Table 70. Tecon Porcine Medicine and Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Tecon Porcine Medicine and Vaccines Product Portfolio Table 72. Tecon Recent Development Table 73. Ringpu Biology Company Information Table 74. Ringpu Biology Business Overview Table 75. Ringpu Biology Porcine Medicine and Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Ringpu Biology Porcine Medicine and Vaccines Product Portfolio Table 77. Ringpu Biology Recent Development Table 78. HVRI Company Information Table 79. HVRI Business Overview Table 80. HVRI Porcine Medicine and Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. HVRI Porcine Medicine and Vaccines Product Portfolio Table 82. HVRI Recent Development Table 83. Hipra Company Information Table 84. Hipra Business Overview Table 85. Hipra Porcine Medicine and Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Hipra Porcine Medicine and Vaccines Product Portfolio Table 87. Hipra Recent Development Table 88. Hile Bio Company Information Table 89. Hile Bio Business Overview Table 90. Hile Bio Porcine Medicine and Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Hile Bio Porcine Medicine and Vaccines Product Portfolio Table 92. Hile Bio Recent Development Table 93. DHN Company Information Table 94. DHN Business Overview Table 95. DHN Porcine Medicine and Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. DHN Porcine Medicine and Vaccines Product Portfolio Table 97. DHN Recent Development Table 98. Chopper Biology Company Information Table 99. Chopper Biology Business Overview Table 100. Chopper Biology Porcine Medicine and Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Chopper Biology Porcine Medicine and Vaccines Product Portfolio Table 102. Chopper Biology Recent Development Table 103. Ceva Company Information Table 104. Ceva Business Overview Table 105. Ceva Porcine Medicine and Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Ceva Porcine Medicine and Vaccines Product Portfolio Table 107. Ceva Recent Development Table 108. CAVAC Company Information Table 109. CAVAC Business Overview Table 110. CAVAC Porcine Medicine and Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. CAVAC Porcine Medicine and Vaccines Product Portfolio Table 112. CAVAC Recent Development Table 113. CAHIC Company Information Table 114. CAHIC Business Overview Table 115. CAHIC Porcine Medicine and Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. CAHIC Porcine Medicine and Vaccines Product Portfolio Table 117. CAHIC Recent Development Table 118. Boehringer Ingelheim Company Information Table 119. Boehringer Ingelheim Business Overview Table 120. Boehringer Ingelheim Porcine Medicine and Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Boehringer Ingelheim Porcine Medicine and Vaccines Product Portfolio Table 122. Boehringer Ingelheim Recent Development Table 123. Bioveta Company Information Table 124. Bioveta Business Overview Table 125. Bioveta Porcine Medicine and Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Bioveta Porcine Medicine and Vaccines Product Portfolio Table 127. Bioveta Recent Development Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Porcine Medicine and Vaccines Product Image Figure 2. Global Porcine Medicine and Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Porcine Medicine and Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Porcine Medicine and Vaccines Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Medicine Image Figure 8. Vaccines Image Figure 9. Global Porcine Medicine and Vaccines Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Porcine Medicine and Vaccines Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Porcine Medicine and Vaccines Sales Value Share by Type (2021-2032) Figure 12. Government Tender Image Figure 13. Market Sales Image Figure 14. Global Porcine Medicine and Vaccines Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Porcine Medicine and Vaccines Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Porcine Medicine and Vaccines Sales Value Share by Application (2021-2032) Figure 17. Global Porcine Medicine and Vaccines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Porcine Medicine and Vaccines Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 19. North America Porcine Medicine and Vaccines Sales Value (2021-2032) & (US$ Million) Figure 20. North America Porcine Medicine and Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 21. Europe Porcine Medicine and Vaccines Sales Value (2021-2032) & (US$ Million) Figure 22. Europe Porcine Medicine and Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Asia-Pacific Porcine Medicine and Vaccines Sales Value (2021-2032) & (US$ Million) Figure 24. Asia-Pacific Porcine Medicine and Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 25. South America Porcine Medicine and Vaccines Sales Value (2021-2032) & (US$ Million) Figure 26. South America Porcine Medicine and Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Middle East & Africa Porcine Medicine and Vaccines Sales Value (2021-2032) & (US$ Million) Figure 28. Middle East & Africa Porcine Medicine and Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 29. USA Porcine Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 30. USA Porcine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 31. USA Porcine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 32. Canada Porcine Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. Canada Porcine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. Canada Porcine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Mexico Porcine Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Mexico Porcine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Mexico Porcine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Germany Porcine Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Germany Porcine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Germany Porcine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. France Porcine Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. France Porcine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. France Porcine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. U.K. Porcine Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. U.K. Porcine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. U.K. Porcine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Italy Porcine Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Italy Porcine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Italy Porcine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Spain Porcine Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Spain Porcine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Spain Porcine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Russia Porcine Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Russia Porcine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Russia Porcine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Netherlands Porcine Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Netherlands Porcine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Netherlands Porcine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Nordic Countries Porcine Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Nordic Countries Porcine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Nordic Countries Porcine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. China Porcine Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. China Porcine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. China Porcine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Japan Porcine Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Japan Porcine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Japan Porcine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. South Korea Porcine Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. South Korea Porcine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. South Korea Porcine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. India Porcine Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. India Porcine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. India Porcine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Australia Porcine Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Australia Porcine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Australia Porcine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Southeast Asia Porcine Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Southeast Asia Porcine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Southeast Asia Porcine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Brazil Porcine Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Brazil Porcine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Brazil Porcine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Argentina Porcine Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Argentina Porcine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Argentina Porcine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Chile Porcine Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Chile Porcine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Chile Porcine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Colombia Porcine Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Colombia Porcine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Colombia Porcine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Peru Porcine Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Peru Porcine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Peru Porcine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Saudi Arabia Porcine Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Saudi Arabia Porcine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Porcine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Israel Porcine Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Israel Porcine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Israel Porcine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. UAE Porcine Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. UAE Porcine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. UAE Porcine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Turkey Porcine Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Turkey Porcine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Turkey Porcine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Iran Porcine Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Iran Porcine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Iran Porcine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Egypt Porcine Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Egypt Porcine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Egypt Porcine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Years Considered Figure 114. Research Process Figure 115. Key Executives Interviewed

Scope & coverage.

Types
  • Medicine
  • Vaccines
Applications
  • Government Tender
  • Market Sales
Companies covered
  • Merck
  • Jinyu Bio-Technology
  • ChengDu Tecbond
  • Zoetis
  • WINSUN
  • Virbac
  • Tecon
  • Ringpu Biology
  • HVRI
  • Hipra
  • Hile Bio
  • DHN
  • Chopper Biology
  • Ceva
  • CAVAC
  • CAHIC
  • Boehringer Ingelheim
  • Bioveta

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Porcine Medicine and Vaccines Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Porcine Medicine and Vaccines Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Porcine Medicine and Vaccines Market Dynamics
  1. 2.1 Porcine Medicine and Vaccines Industry Trends
  2. 2.2 Porcine Medicine and Vaccines Industry Drivers
  3. 2.3 Porcine Medicine and Vaccines Industry Opportunities and Challenges
  4. 2.4 Porcine Medicine and Vaccines Industry Restraints
3 Porcine Medicine and Vaccines Market by Company
  1. 3.1 Global Porcine Medicine and Vaccines Company Revenue Ranking in 2025
  2. 3.2 Global Porcine Medicine and Vaccines Revenue by Company (2021-2026)
  3. 3.3 Global Porcine Medicine and Vaccines Company Ranking (2024-2026)
  4. 3.4 Global Porcine Medicine and Vaccines Company Manufacturing Base and Headquarters
  5. 3.5 Global Porcine Medicine and Vaccines Company Product Type and Application
  6. 3.6 Global Porcine Medicine and Vaccines Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Porcine Medicine and Vaccines Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Porcine Medicine and Vaccines Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Porcine Medicine and Vaccines Market by Type
  1. 4.1 Porcine Medicine and Vaccines Type Introduction
  2. 4.1.1 Medicine
  3. 4.1.2 Vaccines
  4. 4.2 Global Porcine Medicine and Vaccines Sales Value by Type
  5. 4.2.1 Global Porcine Medicine and Vaccines Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Porcine Medicine and Vaccines Sales Value by Type (2021-2032)
  7. 4.2.3 Global Porcine Medicine and Vaccines Sales Value Share by Type (2021-2032)
5 Porcine Medicine and Vaccines Market by Application
  1. 5.1 Porcine Medicine and Vaccines Application Introduction
  2. 5.1.1 Government Tender
  3. 5.1.2 Market Sales
  4. 5.2 Global Porcine Medicine and Vaccines Sales Value by Application
  5. 5.2.1 Global Porcine Medicine and Vaccines Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Porcine Medicine and Vaccines Sales Value by Application (2021-2032)
  7. 5.2.3 Global Porcine Medicine and Vaccines Sales Value Share by Application (2021-2032)
6 Porcine Medicine and Vaccines Regional Value Analysis
  1. 6.1 Global Porcine Medicine and Vaccines Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Porcine Medicine and Vaccines Sales Value by Region (2021-2032)
  3. 6.2.1 Global Porcine Medicine and Vaccines Sales Value by Region: 2021-2026
  4. 6.2.2 Global Porcine Medicine and Vaccines Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Porcine Medicine and Vaccines Sales Value (2021-2032)
  7. 6.3.2 North America Porcine Medicine and Vaccines Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Porcine Medicine and Vaccines Sales Value (2021-2032)
  10. 6.4.2 Europe Porcine Medicine and Vaccines Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Porcine Medicine and Vaccines Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Porcine Medicine and Vaccines Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Porcine Medicine and Vaccines Sales Value (2021-2032)
  16. 6.6.2 South America Porcine Medicine and Vaccines Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Porcine Medicine and Vaccines Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Porcine Medicine and Vaccines Sales Value Share by Country, 2025 VS 2032
7 Porcine Medicine and Vaccines Country-level Value Analysis
  1. 7.1 Global Porcine Medicine and Vaccines Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Porcine Medicine and Vaccines Sales Value by Country (2021-2032)
  3. 7.2.1 Global Porcine Medicine and Vaccines Sales Value by Country (2021-2026)
  4. 7.2.2 Global Porcine Medicine and Vaccines Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Porcine Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Porcine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Porcine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Porcine Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Porcine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Porcine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Porcine Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Porcine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Porcine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Porcine Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Porcine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Porcine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Porcine Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Porcine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Porcine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Porcine Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Porcine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Porcine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Porcine Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Porcine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Porcine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Porcine Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Porcine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Porcine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Porcine Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Porcine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Porcine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Porcine Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Porcine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Porcine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Porcine Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Porcine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Porcine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Porcine Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Porcine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Porcine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Porcine Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Porcine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Porcine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Porcine Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Porcine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Porcine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Porcine Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Porcine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Porcine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Porcine Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Porcine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Porcine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Porcine Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Porcine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Porcine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Porcine Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Porcine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Porcine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Porcine Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Porcine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Porcine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Porcine Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Porcine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Porcine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Porcine Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Porcine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Porcine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Porcine Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Porcine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Porcine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Porcine Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Porcine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Porcine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Porcine Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Porcine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Porcine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Porcine Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Porcine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Porcine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Porcine Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Porcine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Porcine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Porcine Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Porcine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Porcine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Porcine Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Porcine Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Porcine Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Merck
  2. 8.1.1 Merck Company Information
  3. 8.1.2 Merck Business Overview
  4. 8.1.3 Merck Porcine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Merck Porcine Medicine and Vaccines Product Portfolio
  6. 8.1.5 Merck Recent Developments
  7. 8.2 Jinyu Bio-Technology
  8. 8.2.1 Jinyu Bio-Technology Company Information
  9. 8.2.2 Jinyu Bio-Technology Business Overview
  10. 8.2.3 Jinyu Bio-Technology Porcine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Jinyu Bio-Technology Porcine Medicine and Vaccines Product Portfolio
  12. 8.2.5 Jinyu Bio-Technology Recent Developments
  13. 8.3 ChengDu Tecbond
  14. 8.3.1 ChengDu Tecbond Company Information
  15. 8.3.2 ChengDu Tecbond Business Overview
  16. 8.3.3 ChengDu Tecbond Porcine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  17. 8.3.4 ChengDu Tecbond Porcine Medicine and Vaccines Product Portfolio
  18. 8.3.5 ChengDu Tecbond Recent Developments
  19. 8.4 Zoetis
  20. 8.4.1 Zoetis Company Information
  21. 8.4.2 Zoetis Business Overview
  22. 8.4.3 Zoetis Porcine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Zoetis Porcine Medicine and Vaccines Product Portfolio
  24. 8.4.5 Zoetis Recent Developments
  25. 8.5 WINSUN
  26. 8.5.1 WINSUN Company Information
  27. 8.5.2 WINSUN Business Overview
  28. 8.5.3 WINSUN Porcine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  29. 8.5.4 WINSUN Porcine Medicine and Vaccines Product Portfolio
  30. 8.5.5 WINSUN Recent Developments
  31. 8.6 Virbac
  32. 8.6.1 Virbac Company Information
  33. 8.6.2 Virbac Business Overview
  34. 8.6.3 Virbac Porcine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Virbac Porcine Medicine and Vaccines Product Portfolio
  36. 8.6.5 Virbac Recent Developments
  37. 8.7 Tecon
  38. 8.7.1 Tecon Company Information
  39. 8.7.2 Tecon Business Overview
  40. 8.7.3 Tecon Porcine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Tecon Porcine Medicine and Vaccines Product Portfolio
  42. 8.7.5 Tecon Recent Developments
  43. 8.8 Ringpu Biology
  44. 8.8.1 Ringpu Biology Company Information
  45. 8.8.2 Ringpu Biology Business Overview
  46. 8.8.3 Ringpu Biology Porcine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Ringpu Biology Porcine Medicine and Vaccines Product Portfolio
  48. 8.8.5 Ringpu Biology Recent Developments
  49. 8.9 HVRI
  50. 8.9.1 HVRI Company Information
  51. 8.9.2 HVRI Business Overview
  52. 8.9.3 HVRI Porcine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  53. 8.9.4 HVRI Porcine Medicine and Vaccines Product Portfolio
  54. 8.9.5 HVRI Recent Developments
  55. 8.10 Hipra
  56. 8.10.1 Hipra Company Information
  57. 8.10.2 Hipra Business Overview
  58. 8.10.3 Hipra Porcine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Hipra Porcine Medicine and Vaccines Product Portfolio
  60. 8.10.5 Hipra Recent Developments
  61. 8.11 Hile Bio
  62. 8.11.1 Hile Bio Company Information
  63. 8.11.2 Hile Bio Business Overview
  64. 8.11.3 Hile Bio Porcine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Hile Bio Porcine Medicine and Vaccines Product Portfolio
  66. 8.11.5 Hile Bio Recent Developments
  67. 8.12 DHN
  68. 8.12.1 DHN Company Information
  69. 8.12.2 DHN Business Overview
  70. 8.12.3 DHN Porcine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  71. 8.12.4 DHN Porcine Medicine and Vaccines Product Portfolio
  72. 8.12.5 DHN Recent Developments
  73. 8.13 Chopper Biology
  74. 8.13.1 Chopper Biology Company Information
  75. 8.13.2 Chopper Biology Business Overview
  76. 8.13.3 Chopper Biology Porcine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Chopper Biology Porcine Medicine and Vaccines Product Portfolio
  78. 8.13.5 Chopper Biology Recent Developments
  79. 8.14 Ceva
  80. 8.14.1 Ceva Company Information
  81. 8.14.2 Ceva Business Overview
  82. 8.14.3 Ceva Porcine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Ceva Porcine Medicine and Vaccines Product Portfolio
  84. 8.14.5 Ceva Recent Developments
  85. 8.15 CAVAC
  86. 8.15.1 CAVAC Company Information
  87. 8.15.2 CAVAC Business Overview
  88. 8.15.3 CAVAC Porcine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  89. 8.15.4 CAVAC Porcine Medicine and Vaccines Product Portfolio
  90. 8.15.5 CAVAC Recent Developments
  91. 8.16 CAHIC
  92. 8.16.1 CAHIC Company Information
  93. 8.16.2 CAHIC Business Overview
  94. 8.16.3 CAHIC Porcine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  95. 8.16.4 CAHIC Porcine Medicine and Vaccines Product Portfolio
  96. 8.16.5 CAHIC Recent Developments
  97. 8.17 Boehringer Ingelheim
  98. 8.17.1 Boehringer Ingelheim Company Information
  99. 8.17.2 Boehringer Ingelheim Business Overview
  100. 8.17.3 Boehringer Ingelheim Porcine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Boehringer Ingelheim Porcine Medicine and Vaccines Product Portfolio
  102. 8.17.5 Boehringer Ingelheim Recent Developments
  103. 8.18 Bioveta
  104. 8.18.1 Bioveta Company Information
  105. 8.18.2 Bioveta Business Overview
  106. 8.18.3 Bioveta Porcine Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Bioveta Porcine Medicine and Vaccines Product Portfolio
  108. 8.18.5 Bioveta Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst